Provided by Tiger Fintech (Singapore) Pte. Ltd.

TG Therapeutics

40.84
+3.7810.20%
Post-market: 41.000.1600+0.39%19:56 EDT
Volume:4.82M
Turnover:194.91M
Market Cap:6.41B
PE:-411.65
High:41.85
Open:37.50
Low:37.44
Close:37.06
Loading ...

TG Therapeutics Reports Strong 2024 Financial Results and Outlook

TIPRANKS
·
04 Mar

Meta, Netflix Test These Upper Limits As Tesla Exits The Scene While This Biotech Booms

Blockhead
·
04 Mar

Sector Update: Health Care Stocks Rise Monday Afternoon

MT Newswires Live
·
04 Mar

TG Therapeutics Soars Nearly 18% as Strong Q4 Results Fuel Growth Optimism

GuruFocus.com
·
04 Mar

TG Therapeutics (NasdaqCM:TGTX) Reports US$108M Revenue For Q4 2024 With Net Income Of US$23M

Simply Wall St.
·
04 Mar

TG Therapeutics' Shares Rise on 4Q Swing to Profit, Outlook Tops Estimates

Dow Jones
·
04 Mar

BUZZ-TG Therapeutics rises on quarterly net product revenue beat

Reuters
·
04 Mar

TG Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
03 Mar

TG Therapeutics, A New Leaderboard Stock, Skyrockets 17% On Sales Beat, Bullish Guide

Blockhead
·
03 Mar

Sector Update: Health Care Stocks Advance Premarket Monday

MT Newswires Live
·
03 Mar

TG Therapeutics Swings to Quarterly Profit, Targets Higher Revenue in 2025

Dow Jones
·
03 Mar

TG Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
03 Mar

TG Therapeutics Swings to Q4 Net Income, Revenue Rises; 2025 Revenue Guidance Set

MT Newswires Live
·
03 Mar

TG Therapeutics Expects Full Year 2025 Revenue Of Approximately $540M Versus Consensus Of $548.20M, Including Briumvi U.S. Net Product Revenue Of Approximately $525M

Benzinga
·
03 Mar

GUIDANCE: (TGTX) TG Therapeutics Expects Full Year 2025 Global Revenue About $540M, vs. FactSet Est of $534.4M

MT Newswires Live
·
03 Mar

Earnings Flash (TGTX) TG Therapeutics Posts Q4 EPS $0.15, vs. FactSet Est of $0.16

MT Newswires Live
·
03 Mar